DCF — SUTTER MEDICAL CENTER - SACRAMENTO
Enterprise Value: $-209.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-209.0M
Enterprise Value
$-101.5M
PV of Cash Flows
$-107.5M
PV of Terminal Value
$-173.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.4B | $13.8M | 1.0% | $-45.4M | $-41.3M |
| Year 2 | $1.4B | $28.7M | 2.0% | $-32.4M | $-26.7M |
| Year 3 | $1.5B | $44.4M | 3.0% | $-20.3M | $-15.2M |
| Year 4 | $1.5B | $53.4M | 3.0% | $-15.2M | $-10.4M |
| Year 5 | $1.6B | $58.9M | 4.0% | $-12.7M | $-7.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-209.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.004887216190419454
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5